Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $86.93 million. The enterprise value is $67.92 million.
| Market Cap | 86.93M |
| Enterprise Value | 67.92M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 73.05 million shares outstanding. The number of shares has increased by 70.04% in one year.
| Shares Outstanding | 73.05M |
| Shares Change (YoY) | +70.04% |
| Shares Change (QoQ) | +3.33% |
| Owned by Insiders (%) | 9.77% |
| Owned by Institutions (%) | 13.90% |
| Float | 64.48M |
Valuation Ratios
The trailing PE ratio is 13.11 and the forward PE ratio is 19.01. PLX's PEG ratio is -0.10.
| PE Ratio | 13.11 |
| Forward PE | 19.01 |
| PS Ratio | 1.32 |
| Forward PS | 1.70 |
| PB Ratio | 2.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | -0.10 |
Enterprise Valuation
| EV / Earnings | 8.17 |
| EV / Sales | 1.04 |
| EV / EBITDA | 5.83 |
| EV / EBIT | 6.49 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.54 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 2.26 |
| Debt / FCF | n/a |
| Interest Coverage | 5.52 |
Financial Efficiency
Return on equity (ROE) is 29.70% and return on invested capital (ROIC) is 16.96%.
| Return on Equity (ROE) | 29.70% |
| Return on Assets (ROA) | 10.20% |
| Return on Capital (ROIC) | 16.96% |
| Revenue Per Employee | $314,875 |
| Profits Per Employee | $39,962 |
| Employee Count | 208 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.28 |
Taxes
In the past 12 months, PLX has paid $254,000 in taxes.
| Income Tax | 254,000 |
| Effective Tax Rate | 2.97% |
Stock Price Statistics
The stock price has decreased by -51.04% in the last 52 weeks. The beta is 0.89, so PLX's price volatility has been lower than the market average.
| Beta (1Y) | 0.89 |
| 52-Week Price Change | -51.04% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 41.93 |
| Average Volume (30 Days) | 353,674 |
Short Selling Information
The latest short interest is 6.46 million, so 8.84% of the outstanding shares have been sold short.
| Short Interest | 6.46M |
| Short Previous Month | 6.44M |
| Short % of Shares Out | 8.84% |
| Short % of Float | 10.02% |
| Short Ratio (days to cover) | 15.22 |
Income Statement
In the last 12 months, PLX had revenue of $65.49 million and earned $8.31 million in profits. Earnings per share was $0.09.
| Revenue | 65.49M |
| Gross Profit | 42.51M |
| Operating Income | 10.46M |
| Pretax Income | 8.57M |
| Net Income | 8.31M |
| EBITDA | 11.65M |
| EBIT | 10.46M |
| Earnings Per Share (EPS) | $0.09 |
Balance Sheet
The company has $44.56 million in cash and $26.28 million in debt, giving a net cash position of $18.28 million or $0.25 per share.
| Cash & Cash Equivalents | 44.56M |
| Total Debt | 26.28M |
| Net Cash | 18.28M |
| Net Cash Per Share | $0.25 |
| Equity / Book Value | 33.57M |
| Book Value Per Share | 0.46 |
| Working Capital | 24.40M |
Cash Flow
In the last 12 months, operating cash flow was -$1.32 million and capital expenditures -$1.15 million, giving a free cash flow of -$2.47 million.
| Operating Cash Flow | -1.32M |
| Capital Expenditures | -1.15M |
| Free Cash Flow | -2.47M |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 64.91%, with operating and profit margins of 15.97% and 12.69%.
| Gross Margin | 64.91% |
| Operating Margin | 15.97% |
| Pretax Margin | 13.08% |
| Profit Margin | 12.69% |
| EBITDA Margin | 17.79% |
| EBIT Margin | 15.97% |
| FCF Margin | -3.77% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -70.04% |
| Shareholder Yield | -70.04% |
| Earnings Yield | 9.64% |
| FCF Yield | -2.86% |
Analyst Forecast
The average price target for PLX is $10.00, which is 746.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 746.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PLX has an Altman Z-Score of -3.78 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.78 |
| Piotroski F-Score | 6 |